Clinical Trials Browser

Oligodendroglioma × Gefitinib × Clear all

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00025675 2018-06-26

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Clinical Trials

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors